Recent 8-K filings for ATYR

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 20:03 UTC regulatory item 2.02item 7.01item 8.01item 9.01

  aTyr Pharma to launch new Phase 3 study of efzofitimod in pulmonary sarcoidosis after FDA feedback

source · ATYR on sec.gov